- Home
- COEP vs PMAX Comparison
COEP vs PMAX Comparison
Compare COEP & PMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COEP
- PMAX
- Stock Information
- Founded
- COEP 2017
- PMAX 2019
- Country
- COEP United States
- PMAX Hong Kong
- Employees
- COEP N/A
- PMAX N/A
- Industry
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- PMAX
- Sector
- COEP Health Care
- PMAX
- Exchange
- COEP Nasdaq
- PMAX Nasdaq
- Market Cap
- COEP 32.4M
- PMAX 6.6M
- IPO Year
- COEP N/A
- PMAX 2024
- Fundamental
- Price
- COEP $10.30
- PMAX $0.29
- Analyst Decision
- COEP
- PMAX
- Analyst Count
- COEP 0
- PMAX 0
- Target Price
- COEP N/A
- PMAX N/A
- AVG Volume (30 Days)
- COEP 59.8K
- PMAX 7.7M
- Earning Date
- COEP 05-09-2025
- PMAX 03-25-2025
- Dividend Yield
- COEP N/A
- PMAX N/A
- EPS Growth
- COEP N/A
- PMAX N/A
- EPS
- COEP N/A
- PMAX 0.04
- Revenue
- COEP N/A
- PMAX $5,970,263.00
- Revenue This Year
- COEP N/A
- PMAX N/A
- Revenue Next Year
- COEP N/A
- PMAX N/A
- P/E Ratio
- COEP N/A
- PMAX $7.79
- Revenue Growth
- COEP N/A
- PMAX 30.05
- 52 Week Low
- COEP $2.31
- PMAX $0.29
- 52 Week High
- COEP $13.70
- PMAX $4.70
- Technical
- Relative Strength Index (RSI)
- COEP 52.28
- PMAX N/A
- Support Level
- COEP $10.00
- PMAX N/A
- Resistance Level
- COEP $11.58
- PMAX N/A
- Average True Range (ATR)
- COEP 1.33
- PMAX 0.00
- MACD
- COEP -0.14
- PMAX 0.00
- Stochastic Oscillator
- COEP 47.60
- PMAX 0.00
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
About PMAX Powell Max Limited Class A Ordinary Shares
Powell Max Ltd is an financial communications services provider. Its financial communications services cover a full range of financial printing, corporate reporting, communications and language support services from inception to completion, including typesetting, proofreading, translation, design, printing, electronic reporting, newspaper placement and distribution. It operates in a single business segment which is the provision of corporate financial communications and financial printing services. Key revenue is derived from Hong Kong.